亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 磺胺甲惡唑 CAS: 723-46-6
磺胺甲惡唑 CAS: 723-46-6
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 723-46-6
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息
磺胺甲惡唑
CAS: 723-46-6
中文同義詞: 3-對氨基苯磺酰胺基-5-甲基出現被限制詞語;磺安甲出現被限制詞語;磺胺甲基異出現被限制詞語;新明磺;新諾明;磺胺甲基惡唑;4-氨基-N-(5-甲基-3-異惡唑基)苯磺酰胺;磺胺甲基異惡唑
英文名稱: Sulfamethoxazole
英文同義詞: 3-(p-aminophenylsulfonamido)-5-methylisoxazole;3-(para-Aminophenylsulphonamido)-5-methylisoxazole;3-Sulfanilamido-5-methylisoxazole;3-Sulphanilamido-5-methylisoxazole;4-amino-n-(5-methyl-3-isoxazolyl)-benzenesulfonamid;5-Methyl-3-sulfanilamidoisoxazole;5-methyl-3-sulfanylamidoisoxazole;5-Methyl-3-sulfonylamidoisoxazole
分子式: C10H11N3O3S
分子量: 253.28
EINECS號: 211-963-3
標準;cp2005  bp2002
含量:99.0%~101.0%
性狀: 白色結晶性粉末,無臭,味微苦。熔點168℃。極微溶于水,易溶于稀酸、稀堿液或氨水。
用途:磺胺類藥,主要用于治療急慢性尿路感染,也可用于腦膜炎的預防及流感桿菌所致的急性中耳炎等 
包裝:25KG/桶
©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31189  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |